Pyxis Oncology Ownership 2024 | Who Owns Pyxis Oncology Now?
Institutional Ownership
5.47%
Insider Ownership
19.94%
Retail Ownership
74.59%
Institutional Holders
18.00
Pyxis Oncology Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 8.16% | 0.41% | 4,184,100 | - | - | 13,849,371 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 7.53% | 0.15% | 3,861,179 | - | - | 12,780,502 | Jun 30, 2024 |
| BLACKROCK INC. | 5.43% | 0.00% | 2,785,895 | 2,464,230 | 766.09% | 9,221,313 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 5.00% | 0.01% | 2,562,942 | -31,382 | -1.21% | 8,483,338 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.02% | 0.00% | 2,060,444 | 659,019 | 47.02% | 6,820,070 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 3.24% | 0.96% | 1,662,408 | - | - | 5,502,571 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.61% | 0.00% | 1,336,908 | 753,899 | 129.31% | 4,425,165 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 2.34% | 1.17% | 1,202,675 | -591,520 | -32.97% | 3,980,854 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 2.04% | 0.96% | 1,046,025 | 1,046,025 | 100.00% | 3,462,343 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.00% | 0.00% | 1,027,711 | 687,590 | 202.16% | 3,401,994 | Jun 30, 2024 |
| STATE STREET CORP | 1.45% | 0.00% | 742,907 | 633,552 | 579.35% | 2,459,022,000 | Jun 30, 2024 |
| ABRDN PLC | 1.38% | 0.00% | 708,303 | - | - | 2,344,483 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.96% | 0.04% | 492,462 | - | - | 1,630,049 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.94% | 2.02% | 484,443 | -9,316 | -1.89% | 1,603,506 | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | 0.75% | 0.03% | 382,606 | - | - | 1,266,426 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | 0.64% | 0.33% | 326,810 | - | - | 1,081,741 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.61% | 0.00% | 311,630 | 149,522 | 92.24% | 1,031,495 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.48% | 0.02% | 246,495 | 15,000 | 6.48% | 815,898 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.46% | 0.00% | 238,390 | 73,390 | 44.48% | 789,071 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.29% | 0.00% | 149,024 | 149,024 | 100.00% | 493,270 | Jun 30, 2024 |
Pyxis Oncology's largest institutional shareholder is DEEP TRACK CAPITAL, LP, holding 8.16% of the company's total share outstanding, currently valued at $13.85M. The top 10 institutional shareholders own together 42.37% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.94% | 2.02% | 484,443 | -9,316 | -1.89% | 1,603,506 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 2.34% | 1.17% | 1,202,675 | -591,520 | -32.97% | 3,980,854 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 2.04% | 0.96% | 1,046,025 | 1,046,025 | 100.00% | 3,462,343 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 3.24% | 0.96% | 1,662,408 | - | - | 5,502,571 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 8.16% | 0.41% | 4,184,100 | - | - | 13,849,371 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | 0.64% | 0.33% | 326,810 | - | - | 1,081,741 | Jun 30, 2024 |
| YU FAN | 0.14% | 0.30% | 69,303 | - | - | 229,393 | Jun 30, 2024 |
| CABLE CAR CAPITAL LLC | 0.12% | 0.21% | 61,606 | - | - | 203,916 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.01% | 0.21% | 3,586 | 3,586 | 100.00% | 1,186,966 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 7.53% | 0.15% | 3,861,179 | - | - | 12,780,502 | Jun 30, 2024 |
| UNIVERSITY OF CHICAGO | 0.10% | 0.12% | 48,731 | - | - | 161,300 | Jun 30, 2024 |
| PIER 88 INVESTMENT PARTNERS LLC | 0.22% | 0.08% | 113,700 | 62,340 | 121.38% | 376,347 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.23% | 0.07% | 115,514 | 115,514 | 100.00% | 382,351 | Jun 30, 2024 |
| SCHULHOFF & CO INC | 0.08% | 0.06% | 42,000 | 20,000 | 90.91% | 139,020 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.96% | 0.04% | 492,462 | - | - | 1,630,049 | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | 0.75% | 0.03% | 382,606 | - | - | 1,266,426 | Jun 30, 2024 |
| FULLCIRCLE WEALTH LLC | 0.02% | 0.02% | 12,000 | 12,000 | 100.00% | 45,240 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.48% | 0.02% | 246,495 | 15,000 | 6.48% | 815,898 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 5.00% | 0.01% | 2,562,942 | -31,382 | -1.21% | 8,483,338 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.07% | 0.01% | 36,290 | -29,572 | -44.90% | 120,120 | Jun 30, 2024 |
The largest Pyxis Oncology shareholder by % of total assets is SUPERSTRING CAPITAL MANAGEMENT LP. The company owns 484.44K shares of Pyxis Oncology (PYXS), representing 2.02% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 5.43% | 0.00% | 2,785,895 | 2,464,230 | 766.09% | 9,221,313 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 2.04% | 0.96% | 1,046,025 | 1,046,025 | 100.00% | 3,462,343 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.61% | 0.00% | 1,336,908 | 753,899 | 129.31% | 4,425,165 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.00% | 0.00% | 1,027,711 | 687,590 | 202.16% | 3,401,994 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.02% | 0.00% | 2,060,444 | 659,019 | 47.02% | 6,820,070 | Jun 30, 2024 |
| STATE STREET CORP | 1.45% | 0.00% | 742,907 | 633,552 | 579.35% | 2,459,022,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.61% | 0.00% | 311,630 | 149,522 | 92.24% | 1,031,495 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.29% | 0.00% | 149,024 | 149,024 | 100.00% | 493,270 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.23% | 0.07% | 115,514 | 115,514 | 100.00% | 382,351 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.25% | 0.00% | 129,761 | 115,237 | 793.42% | 429,509 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.19% | 0.01% | 99,100 | 99,100 | 100.00% | 328,021 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.19% | 0.00% | 95,703 | 95,703 | 100.00% | 316,777 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.46% | 0.00% | 238,390 | 73,390 | 44.48% | 789,071 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.25% | 0.00% | 128,396 | 67,162 | 109.68% | 424,991,000 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.13% | 0.00% | 65,287 | 65,287 | 100.00% | 216,093 | Jun 30, 2024 |
| PIER 88 INVESTMENT PARTNERS LLC | 0.22% | 0.08% | 113,700 | 62,340 | 121.38% | 376,347 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.08% | 0.00% | 40,756 | 40,756 | 100.00% | 134,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.16% | - | 82,611 | 39,084 | 89.79% | 273,443 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.06% | 0.00% | 31,200 | 31,200 | 100.00% | 103,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 26,273 | 26,273 | 100.00% | 87,226 | Jun 30, 2024 |
As of Jun 30 2024, Pyxis Oncology's largest institutional buyer is BLACKROCK INC.. The company purchased 2.46M stocks of PYXS, valued at $9.22M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STEMPOINT CAPITAL LP | 2.34% | 1.17% | 1,202,675 | -591,520 | -32.97% | 3,980,854 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -442,500 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.23% | 0.00% | 117,248 | -219,443 | -65.18% | 388,091 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -139,142 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.02% | - | 10,000 | -123,576 | -92.51% | 33,100 | Jun 30, 2024 |
| MAN GROUP PLC | 0.10% | 0.00% | 52,954 | -94,226 | -64.02% | 175,278 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.13% | 0.00% | 68,012 | -84,994 | -55.55% | 225,120 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | - | - | - | -74,903 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -68,358 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.19% | 0.00% | 96,936 | -51,064 | -34.50% | 320,858 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -42,400 | -100.00% | - | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 16,380 | -40,620 | -71.26% | 54,218 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -35,987 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 5.00% | 0.01% | 2,562,942 | -31,382 | -1.21% | 8,483,338 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -29,835 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | 0.07% | 0.01% | 36,290 | -29,572 | -44.90% | 120,120 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -28,053 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.03% | 0.00% | 13,883 | -26,569 | -65.68% | 45,953 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.11% | 0.00% | 57,025 | -25,422 | -30.83% | 188,753 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.16% | 0.00% | 81,934 | -19,876 | -19.52% | 271,202 | Jun 30, 2024 |
As of Jun 30 2024, Pyxis Oncology's biggest institutional seller is STEMPOINT CAPITAL LP. The company sold -0.59M shares of PYXS, valued at $3.98M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLUE OWL CAPITAL HOLDINGS LP | 2.04% | 0.96% | 1,046,025 | 1,046,025 | 100.00% | 3,462,343 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.29% | 0.00% | 149,024 | 149,024 | 100.00% | 493,270 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.23% | 0.07% | 115,514 | 115,514 | 100.00% | 382,351 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.19% | 0.01% | 99,100 | 99,100 | 100.00% | 328,021 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.13% | 0.00% | 65,287 | 65,287 | 100.00% | 216,093 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.08% | 0.00% | 40,756 | 40,756 | 100.00% | 134,000 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.06% | 0.00% | 31,200 | 31,200 | 100.00% | 103,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 26,273 | 26,273 | 100.00% | 87,226 | Jun 30, 2024 |
| INVESCO LTD. | 0.04% | - | 22,103 | 22,103 | 100.00% | 73,161 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.04% | 0.00% | 19,730 | 19,730 | 100.00% | 65,306 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 17,199 | 17,199 | 100.00% | 56,929 | Jun 30, 2024 |
| BARCLAYS PLC | 0.03% | - | 17,092 | 17,092 | 100.00% | 57,000 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.03% | 0.00% | 16,205 | 16,205 | 100.00% | 53,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.03% | - | 13,470 | 13,470 | 100.00% | 44,586 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.03% | 0.00% | 13,334 | 13,334 | 100.00% | 44,136 | Jun 30, 2024 |
| FULLCIRCLE WEALTH LLC | 0.02% | 0.02% | 12,000 | 12,000 | 100.00% | 45,240 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 4,784 | 4,784 | 100.00% | 15,835 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 4,219 | 4,219 | 100.00% | 13,881 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.01% | 0.21% | 3,586 | 3,586 | 100.00% | 1,186,966 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 3,539 | 3,539 | 100.00% | 11,714 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | 0.00% | 1,690 | 1,690 | 100.00% | 6,000 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 1,400 | 1,400 | 100.00% | 4,634 | Jun 30, 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 0.00% | 0.00% | 1,050 | 1,050 | 100.00% | 3,476 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 500 | 500 | 100.00% | 1,655 | Jun 30, 2024 |
Pyxis Oncology's largest new institutional shareholder by number of shares is BLUE OWL CAPITAL HOLDINGS LP, purchased 1.05M shares, valued at $3.46M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -442,500 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -139,142 | -100.00% | - | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | - | - | - | -74,903 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -68,358 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -42,400 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -35,987 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -29,835 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -28,053 | -100.00% | - | Jun 30, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | - | - | - | -16,238 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -13,809 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -11,800 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -9,706 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -1,113 | -100.00% | - | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| WEST BRANCH CAPITAL LLC | - | - | - | -25 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Pyxis Oncology's largest sold out institutional shareholder by shares sold is MONASHEE INVESTMENT MANAGEMENT LLC, sold -0.44M shares, valued at -, as of undefined.
Pyxis Oncology Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA HEALTHCARE INVESTORS | 0.56% | 481,646 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.48% | 226,657 | - | - | Mar 31, 2024 |
| Tema ETF Trust | 0.36% | 16,000 | 16,000 | - | Feb 29, 2024 |
| BRIDGEWAY FUNDS INC | 0.10% | 231,495 | -4,700 | -1.99% | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,351,502 | -323,251 | -19.30% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,727 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 15,394 | - | - | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 36,737 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 255,812 | -9,859 | -3.71% | Feb 29, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 152,824 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 10,221 | -1,394 | -12.00% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 822 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 6,524 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 15,028 | 1,257 | 9.13% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 616 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 30,112 | -30,445 | -50.27% | Jan 31, 2024 |
| Global X Funds | 0.00% | 2,984 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 45,578 | -27,697 | -37.80% | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 5,549 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 2,400 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 80,353 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 227 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 35,731 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 500 | - | - | Mar 28, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,664 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 61 | - | - | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 317 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 56 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 3,941 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,582 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 62 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 10 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,017 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 1,521 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 700 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 16,163 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 5,930 | 672 | 12.78% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 77,660 | 254 | 0.33% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 4,382 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,172 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 7,700 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 64 | - | - | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 12,210 | - | - | Mar 28, 2024 |
| PACIFIC SELECT FUND | 0.00% | 5,092 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 954 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 2,329 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,574 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 721 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,375 | - | - | Feb 29, 2024 |
Pyxis Oncology's largest mutual fund holder by % of total assets is "TEKLA HEALTHCARE INVESTORS", owning 481.65K shares, compromising 0.56% of its total assets.
Pyxis Oncology Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 18 | -76.32% |
| 31 Mar, 24 | 76 | 46.15% |
| 31 Dec, 23 | 52 | 4.00% |
| 30 Sep, 23 | 50 | 6.38% |
| 30 Jun, 23 | 47 | - |
| 31 Mar, 23 | 47 | 51.61% |
| 31 Dec, 22 | 31 | -11.43% |
| 30 Sep, 22 | 35 | -5.41% |
| 30 Jun, 22 | 37 | -17.78% |
| 31 Mar, 22 | 45 | -11.76% |
| 31 Dec, 21 | 51 | - |
As of 30 Jun 24, 18 institutions are holding Pyxis Oncology's shares, representing a decrease of -76.32% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 2,806,745 | -87.77% |
| 31 Mar, 24 | 22,952,291 | 161.33% |
| 31 Dec, 23 | 8,782,945 | 13.39% |
| 30 Sep, 23 | 7,745,767 | -19.36% |
| 30 Jun, 23 | 9,605,170 | -7.24% |
| 31 Mar, 23 | 10,354,999 | -47.60% |
| 31 Dec, 22 | 19,762,209 | 1.64% |
| 30 Sep, 22 | 19,443,950 | -2.95% |
| 30 Jun, 22 | 20,034,464 | 5.74% |
| 31 Mar, 22 | 18,946,339 | 3.31% |
| 31 Dec, 21 | 18,338,628 | - |
Pyxis Oncology (PYXS) has 2.81M shares outstanding as of 30 Jun 24, down -87.77% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 5.47% | 0.21% |
| 31 Mar, 24 | 51.28% | 11.36% |
| 31 Dec, 23 | 21.25% | 5.22% |
| 30 Sep, 23 | 20.18% | 2.73% |
| 30 Jun, 23 | 27.17% | 3.17% |
| 31 Mar, 23 | 29.29% | 0.82% |
| 31 Dec, 22 | 59.83% | 1.68% |
| 30 Sep, 22 | 59.72% | 1.57% |
| 30 Jun, 22 | 61.74% | 1.80% |
| 31 Mar, 22 | 58.63% | 1.76% |
| 31 Dec, 21 | 57.79% | - |
As of 30 Jun 24, Pyxis Oncology is held by 5.47% institutional shareholders, representing a 0.21% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 12 | -77.78% |
| 31 Mar, 24 | 54 | 200.00% |
| 31 Dec, 23 | 18 | -30.77% |
| 30 Sep, 23 | 26 | -23.53% |
| 30 Jun, 23 | 34 | 6.25% |
| 31 Mar, 23 | 32 | 113.33% |
| 31 Dec, 22 | 15 | -6.25% |
| 30 Sep, 22 | 16 | -15.79% |
| 30 Jun, 22 | 19 | - |
| 31 Mar, 22 | 19 | -62.75% |
| 31 Dec, 21 | 51 | - |
12 institutional shareholders have increased their position in PYXS stock as of 30 Jun 24 compared to 54 in the previous quarter (a -77.78% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -25.00% |
| 31 Mar, 24 | 4 | -63.64% |
| 31 Dec, 23 | 11 | -15.38% |
| 30 Sep, 23 | 13 | 116.67% |
| 30 Jun, 23 | 6 | -14.29% |
| 31 Mar, 23 | 7 | 16.67% |
| 31 Dec, 22 | 6 | -14.29% |
| 30 Sep, 22 | 7 | -46.15% |
| 30 Jun, 22 | 13 | -7.14% |
| 31 Mar, 22 | 14 | - |
| 31 Dec, 21 | - | - |
3 institutional shareholders have reduced their position in PYXS stock as of 30 Jun 24 compared to 4 in the previous quarter (a -25.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 18 | -76.32% | 2,806,745 | -87.77% | 5.47% | 0.21% | 12 | -77.78% | 3 | -25.00% |
| 31 Mar, 24 | 76 | 46.15% | 22,952,291 | 161.33% | 51.28% | 11.36% | 54 | 200.00% | 4 | -63.64% |
| 31 Dec, 23 | 52 | 4.00% | 8,782,945 | 13.39% | 21.25% | 5.22% | 18 | -30.77% | 11 | -15.38% |
| 30 Sep, 23 | 50 | 6.38% | 7,745,767 | -19.36% | 20.18% | 2.73% | 26 | -23.53% | 13 | 116.67% |
| 30 Jun, 23 | 47 | - | 9,605,170 | -7.24% | 27.17% | 3.17% | 34 | 6.25% | 6 | -14.29% |
| 31 Mar, 23 | 47 | 51.61% | 10,354,999 | -47.60% | 29.29% | 0.82% | 32 | 113.33% | 7 | 16.67% |
| 31 Dec, 22 | 31 | -11.43% | 19,762,209 | 1.64% | 59.83% | 1.68% | 15 | -6.25% | 6 | -14.29% |
| 30 Sep, 22 | 35 | -5.41% | 19,443,950 | -2.95% | 59.72% | 1.57% | 16 | -15.79% | 7 | -46.15% |
| 30 Jun, 22 | 37 | -17.78% | 20,034,464 | 5.74% | 61.74% | 1.80% | 19 | - | 13 | -7.14% |
| 31 Mar, 22 | 45 | -11.76% | 18,946,339 | 3.31% | 58.63% | 1.76% | 19 | -62.75% | 14 | - |
| 31 Dec, 21 | 51 | - | 18,338,628 | - | 57.79% | - | 51 | - | - | - |
Pyxis Oncology Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Pyxis Oncology's stock was made by Connealy Pamela Ann on Nov 30 2023, selling 36,949 shares at $1.40 per share (valued at $51.73K). The last insider buy of PYXS was made by Connealy Pamela Ann on Sep 28 2023, buying 8,000 shares at $1.87 per share (worth $14.96K).
Pyxis Oncology Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 2 | - | - |
| Q1 2024 | 10 | - | - |
| Q4 2023 | 3 | 1 | 300.00% |
| Q3 2023 | 14 | 6 | 233.33% |
| Q1 2023 | 22 | 5 | 440.00% |
| Q4 2022 | - | 1 | - |
| Q3 2022 | 2 | 2 | 100.00% |
| Q2 2022 | 3 | 1 | 300.00% |
| Q1 2022 | 8 | - | - |
| Q4 2021 | 19 | 24 | 79.17% |
2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Pyxis Oncology's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | 7 | 5 | 140.00% |
| Q1 2023 | 2 | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 4 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Pyxis Oncology's stocks.
Pyxis Oncology Peer Ownership
| Ticker | Company |
|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| PDSB | PDS Biotechnology Corporation |
| HOOK | HOOKIPA Pharma Inc. |
| CRVS | Corvus Pharmaceuticals, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| EFTR | eFFECTOR Therapeutics, Inc. |
| CYTO | Altamira Therapeutics Ltd. |
| OCEA | Ocean Biomedical, Inc. |
| ZURA | Zura Bio Limited |
| ELEV | Elevation Oncology, Inc. |
PYXS Ownership FAQ
Who Owns Pyxis Oncology?
Pyxis Oncology is owned by institutional shareholders (5.47%), insiders (19.94%), and public (74.59%). The largest institutional shareholder of Pyxis Oncology is DEEP TRACK CAPITAL, LP (8.16% of total shares) and the top mutual fund owner is TEKLA HEALTHCARE INVESTORS (0.56% of total shares).
Who are the major institutional shareholders of Pyxis Oncology?
Pyxis Oncology's major institutional shareholders are DEEP TRACK CAPITAL, LP, LAURION CAPITAL MANAGEMENT LP, BLACKROCK INC., BALYASNY ASSET MANAGEMENT L.P., and VANGUARD GROUP INC. The top five shareholders own together 30.13% of the company's share outstanding.
How many Pyxis Oncology shareholders are there?
As of Jun 2024, there are 18 institutional shareholders of Pyxis Oncology.
What percentage of Pyxis Oncology is owned by DEEP TRACK CAPITAL, LP?
DEEP TRACK CAPITAL, LP owns 4.18M shares of Pyxis Oncology, representing 8.16% of the company's total shares outstanding, valued at $13.85M (as of Jun 2024).
What percentage of Pyxis Oncology is owned by LAURION CAPITAL MANAGEMENT LP?
As of Jun 2024, LAURION CAPITAL MANAGEMENT LP holds 3.86M shares of Pyxis Oncology (PYXS), compromising 7.53% of the company, valued at $12.78M.
What percentage of Pyxis Oncology is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Pyxis Oncology. The company owns 2.79M of the company's shares outstanding (worth $9.22M).